LifeArc Translational Science Summit
When
Where
About the event
The LifeArc Translational Science Summit will delve into how translational research accelerates the journey from scientific discovery to real-world impact – particularly in rare diseases – by advancing treatments, shaping clinical practice, influencing health policy, and driving commercial innovation. This exclusive, full-day event brings together leading scientists, clinicians, industry experts, policy makers, and investors to share insights and foster collaboration.
Speaker highlights
Apply to attend
Please complete this form to request a ticket.
We will aim to confirm whether your application has been successful within 5 working days.
<div style="text-align: center; font-size:22px;"> <span style="font-family: Halyard1, sans-serif; font-size: 14px; color: rgb(26, 26, 26);">Thank you for your interest in attending the LifeArc Translational Science Summit.</span> </div> <div style="text-align: center; font-size:22px;"> <span style="font-size: 14px;"><span style="font-family: 'Halyard1', sans-serif;"><span style="color: rgb(26, 26, 26);">We will email you shortly to confirm if you have been allocated a place at the event.<br /></span></span></span> </div> <div style="text-align: center; font-size:22px;"> <span style="font-size: 14px;"><span style="font-family: 'Halyard1', sans-serif;"> </span><span style="font-family: Halyard1, sans-serif; color: rgb(26, 26, 26);">If you do not hear from us within 10 working days, please contact <a href="mailto:events@lifearc.org">events@lifearc.org</a>.</span><br /></span> </div>
About LifeArc
LifeArc is a self-funded medical research organisation with one clear purpose – transforming the lives of people living with rare diseases and global health infections.
We aim to deliver this by conducting, funding and investing in pioneering research, and working with partners to accelerate the translation of scientific breakthroughs into new tests and treatments.
Our vision is a world where people living with rare diseases and drug-resistant infections can access effective, life-changing treatments faster.